Literature DB >> 11854689

Myofibroblasts are responsible for the desmoplastic reaction surrounding human pancreatic carcinomas.

Tina W f Yen1, Nils Petter Aardal, Mary P Bronner, David R Thorning, Christopher E Savard, Sum P Lee, Richard H Bell.   

Abstract

BACKGROUND: The cell type responsible for the desmoplastic reaction surrounding human pancreatic carcinoma is unknown. Hepatic stellate cells, which activate to a myofibroblast-like form, are responsible for collagen deposition in cirrhosis and around hepatocellular carcinomas. Recently, pancreatic stellate cells have been described and implicated in the fibrosis of chronic pancreatitis. We sought to determine whether these cells are responsible for the scirrhous reaction surrounding pancreatic adenocarcinomas.
METHODS: Archival formalin-fixed, paraffin-embedded pancreatic tissues from 10 patients undergoing pancreaticoduodenectomy for ductal adenocarcinoma and from 2 patients with pancreatic islet cell tumors were examined immunohistochemically for alpha-smooth muscle actin (alpha-SMA), smooth muscle myosin heavy chain (SMMHC), procollagen I, collagen IV, and endothelial cell markers, von Willebrand factor and cluster of differentiation 31.
RESULTS: In non-neoplastic areas, staining for alpha-SMA and SMMHC was confined to interlobular septal regions. In contrast, the desmoplastic reaction surrounding all 10 pancreatic adenocarcinoma specimens displayed intense interstitial staining for alpha-SMA, SMMHC, and collagen IV but no staining for von Willebrand factor and cluster of differentiation 31. Procollagen I staining localized intracellularly to fibroblast-shaped cells within this alpha-SMA/SMMHC-positive scirrhous region. Islet cell tumors demonstrated an increase in alpha-SMA staining, although this was not as marked as in ductal adenocarcinomas.
CONCLUSIONS: A massive increase in myofibroblast activity, compatible with the activation of stellate cells, is associated with the deposition of collagen types I and IV in the desmoplastic reaction around pancreatic adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11854689     DOI: 10.1067/msy.2002.119192

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  46 in total

1.  Stellate cells in the digestive tract.

Authors:  Hendrik Reynaert; Filip Sermon; Daniel Urbain; Albert Geerts
Journal:  Curr Gastroenterol Rep       Date:  2003-06

Review 2.  The pancreatic stellate cell: a star on the rise in pancreatic diseases.

Authors:  M Bishr Omary; Aurelia Lugea; Anson W Lowe; Stephen J Pandol
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

3.  Antifibrotic Therapy Disrupts Stromal Barriers and Modulates the Immune Landscape in Pancreatic Ductal Adenocarcinoma.

Authors:  Kianna Y Elahi-Gedwillo; Marjorie Carlson; Jon Zettervall; Paolo P Provenzano
Journal:  Cancer Res       Date:  2018-11-06       Impact factor: 12.701

Review 4.  Therapeutic potential of perineural invasion, hypoxia and desmoplasia in pancreatic cancer.

Authors:  Han Liu; Qingyong Ma; Qinhong Xu; Jianjun Lei; Xuqi Li; Zheng Wang; Erxi Wu
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

5.  TGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3.

Authors:  Rachel A Hesler; Jennifer J Huang; Mark D Starr; Victoria M Treboschi; Alyssa G Bernanke; Andrew B Nixon; Shannon J McCall; Rebekah R White; Gerard C Blobe
Journal:  Carcinogenesis       Date:  2016-11-01       Impact factor: 4.944

Review 6.  Tumor-stromal interactions in pancreatic cancer.

Authors:  Clifford Whatcott; Haiyong Han; Richard G Posner; Daniel D Von Hoff
Journal:  Crit Rev Oncog       Date:  2013

Review 7.  Pancreatic stellate cells--role in pancreas cancer.

Authors:  Max G Bachem; Shaoxia Zhou; Karin Buck; Wilhelm Schneiderhan; Marco Siech
Journal:  Langenbecks Arch Surg       Date:  2008-01-17       Impact factor: 3.445

Review 8.  Triggering the landslide: The tumor-promotional effects of myofibroblasts.

Authors:  Christine Mehner; Derek C Radisky
Journal:  Exp Cell Res       Date:  2013-03-22       Impact factor: 3.905

Review 9.  Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer: Normalization, Not Destruction.

Authors:  Clifford J Whatcott; Haiyong Han; Daniel D Von Hoff
Journal:  Cancer J       Date:  2015 Jul-Aug       Impact factor: 3.360

10.  L1CAM promotes enrichment of immunosuppressive T cells in human pancreatic cancer correlating with malignant progression.

Authors:  Evelin Grage-Griebenow; Elfi Jerg; Artur Gorys; Daniel Wicklein; Daniela Wesch; Sandra Freitag-Wolf; Lisa Goebel; Ilka Vogel; Thomas Becker; Michael Ebsen; Christoph Röcken; Peter Altevogt; Udo Schumacher; Heiner Schäfer; Susanne Sebens
Journal:  Mol Oncol       Date:  2014-04-02       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.